Page 60 - Read Online
P. 60

conductivity had greatest differences in effect seen in   of ablation, which was contrary to previous reports. [29,30]
            tumor range. Therefore, some researchers suggested that   In the current study, one patient whose tumor was seen
            when tumor size > 2 cm, repeated RFA or combination   adjacent to the portal vein, hepatic artery, and bile duct
            treatment  may  be  beneficial.  Second,  as  reported  by   by  enhanced  CT  died  due  to  liver  failure.  Using  a  pig
                                                                            [31]
            Kim  et al.,  a margin of 3 mm or more is associated   model, Lu et al.  found that when vessel size was > 3
                     [20]
            with a lower rate of local tumor recurrence after   cm, HSE and river-flow effect occurred. Heat could be
            percutaneous RFA of HCC. Some clinicians have reported   carried  away  by  the  blood  flow,  infusing  into  regional
            difficulty in obtaining adequate circumferential ablative   hepatic segments or lobes along the blood flow, causing
            margin for large tumors after a single-session of RFA.   thermal lesion to liver cells and finally impairing liver
                                                                                            [9]
            Overlapping treatment or combining with transcatheter   function with sustained high heat.  Hence, to achieve
            arterial chemoembolization were needed.  Third, the   “one-off ” ablation and decrease these complications,
                                                [21]
            effectiveness of RFA may be related with the perfusion of   laparoscopic approaches or pringle maneuver seem to be
            the tumor, although it is still debated. Some researchers   appropriate for tumors close to vasculature. [31,32]
            found that RFA with occlusion of tumor blood supply in
            tumors measuring 3.5 cm was beneficial.  Documented   This study has several limitations. First, most patients did
                                              [22]
            pathology showed that blood supplies changed as tumors   not have pathological examination. The diagnosis of HCC
            grow larger. As the perfusion of tumors aggravated,   relied on their hepatitis history and imaging examination.
            the “heat-sink effect” (HSE) may be induced which will   Therefore, it is possible that benign liver diseases were
            influence the effectiveness of the RFA. [23]       included, which may influence the judgment of “one-off ”
                                                               ablation. Second, all RFA procedures were performed by
            In addition to tumor size, proximity of the tumor   the same team, which may introduce bias to our results.
            to organs is also one of the most important factors   Third, our study was a retrospective study, and limited to
            influencing the success of “one-off ” ablation. In the clinic,   single-center (Eastern Hepatobiliary Surgery Hospital).
            tumors adjacent to gallbladder, kidney, diaphragm, and   Further analyses including randomized controlled trials
            so on were thought to be high-risk.  Local ablation for   in multi-center sites are needed.
                                          [24]
            tumors in “high-risk” location is technically challenging
            because of the poor visibility of the tumor and for fear   In conclusion, for single HCC with diameters smaller
            of collateral thermal injury to the adjacent organs and   than 3 cm and which are further from organs, “one-
            causing serious post-operative complications. [25,26]  The   off ”  percutaneous  RFA  was  beneficial.  Our  study  also
            complication rate of our study is 4.3%, similar to the   elucidated the scientific rationale of RFA treatment
            report of Lau and Lai,  which indicated a complication   criteria (AASLD and EASL) for HCC regarding tumor size.
                              [15]
                                                               For tumors located at specific sites of the liver, open or
            rate of RFA ranging from 3% to 7%. Most patients   laparoscopic RFA or combination with other techniques
            experienced mild pain or discomfort during the ablation.   may be a better choice.
            Six patients had bile leakage on the 3rd or 4th post-
            operative day. One patient died from liver failure. These
            tumors were all located in “high-risk” areas. To achieve   Financial support and sponsorship
                                                               This work was supported by the National Natural Science
            better ablation effects, some clinicians suggest departing   Foundation (No. 81441063) and SMMU Stem Cell and
                                                       [27]
            the vulnerable structures from the area of ablation  or   Medicine Research Center’s Innovation Research Program
                                       [28]
            using laparoscopic ablation (LA).  L A was proved to be   (No. 1406).
            a safe and effective technique for high-risk lesions not
            manageable by percutaneous approach and not suitable   Conflicts of interest
            for surgical resection. [28]
                                                               There are no conflicts of interest.
            Surprisingly, our study indicated that tumor close to   REFERENCES
            vascular and capsular sites did not influence the success
            of  “one-off ”  RFA.  Tumor  located  near  the  capsular   1.   Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of
            has no influence on the success of “one-off ” ablation,   liver disease: the major impact of China. Hepatology 2014;60:2099-
            which is contrary to Komorizono’s retrospective study   108.
            that  showed patients who had sub-capsular tumors   2.   Schwartz M. Liver transplantation for hepatocellular carcinoma.
            had significantly shorter recurrence free intervals   3.   Gastroenterology 2004;127:S268-76.
                                                                  Feng K, Ma KS. Value of radiofrequency ablation in the treatment
            compared with patients who had non-sub-capsular       of hepatocellular carcinoma. World J Gastroenterol 2014;20:5987-
            tumors.  Further prospective study is needed to clarify   98.
                  [18]
            this inconsistency. In addition, whether tumor close   4.   Wood  TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik
            to  vascular will influence the  effectiveness of  ablation   AJ. Radiofrequency ablation of 231 unresectable hepatic tumors:
            is also unclear. Our result is similar to the study of   indications, limitations, and complications.  Ann Surg Oncol
                                                                  2000;7:593-600.
            Komorizono et al.  which also showed that proximity   5.   Ansari D, Andersson R. Radiofrequency ablation or percutaneous
                           [18]
            of a tumor to vessel did not influence the local effect   ethanol  injection  for  the  treatment  of  liver  tumors.  World  J

                 Hepatoma Research | Volume 2 | Issue 2 | February 29, 2016                                51
   55   56   57   58   59   60   61   62   63   64   65